Combined hepatocellular-cholangiocarcinoma: A case report

C. H. Toh; Y. C. Cheung; Shu Hang Ng; C. Y. Lin; S. C. Chan; K. K. Ng

doi:10.1111/j.1742-1241.2004.00110.x

Combined hepatocellular-cholangiocarcinoma: A case report

C. H. Toh, Y. C. Cheung, Shu Hang Ng^*, C. Y. Lin, S. C. Chan, K. K. Ng

^*Corresponding author for this work

Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Article › peer-review

9 Scopus citations

Abstract

Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a rare primary liver tumour. We report a carrier of both HBV and HCV presenting with intermittent abdominal pain, fever, chillness and elevated á-fetoprotein (AFP) of 1197 ng/ml. Computed tomography showed an irregular hypodense mass in the left lateral segment of the liver with vague contrast enhancement and multiple regional lymphadenopathy. Hepatic angiogram showed that the mass was hypovascular and the left portal vein was occluded with a tapered end. Percutaneous ultrasound-guided core needle biopsy of the liver yielded HCC-CC. We suggest that HCC-CC should be considered in hypovascular liver tumours with striking elevation of serum AFP and multiple regional lymphadenopathy.

Original language	English
Pages (from-to)	1170-1173
Number of pages	4
Journal	International Journal of Clinical Practice
Volume	58
Issue number	12
DOIs	https://doi.org/10.1111/j.1742-1241.2004.00110.x
State	Published - 12 2004
Externally published	Yes

Keywords

Combined hepatocellular-cholangiocarcinoma
Liver neoplasm

Access to Document

10.1111/j.1742-1241.2004.00110.x

Cite this

@article{f04bc119d78048839d3095cdf35730ec,

title = "Combined hepatocellular-cholangiocarcinoma: A case report",

abstract = "Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a rare primary liver tumour. We report a carrier of both HBV and HCV presenting with intermittent abdominal pain, fever, chillness and elevated {\'a}-fetoprotein (AFP) of 1197 ng/ml. Computed tomography showed an irregular hypodense mass in the left lateral segment of the liver with vague contrast enhancement and multiple regional lymphadenopathy. Hepatic angiogram showed that the mass was hypovascular and the left portal vein was occluded with a tapered end. Percutaneous ultrasound-guided core needle biopsy of the liver yielded HCC-CC. We suggest that HCC-CC should be considered in hypovascular liver tumours with striking elevation of serum AFP and multiple regional lymphadenopathy.",

keywords = "Combined hepatocellular-cholangiocarcinoma, Liver neoplasm",

author = "Toh, {C. H.} and Cheung, {Y. C.} and Ng, {Shu Hang} and Lin, {C. Y.} and Chan, {S. C.} and Ng, {K. K.}",

year = "2004",

month = dec,

doi = "10.1111/j.1742-1241.2004.00110.x",

language = "英语",

volume = "58",

pages = "1170--1173",

journal = "International Journal of Clinical Practice",

issn = "1368-5031",

publisher = "Hindawi Limited",

number = "12",

}

TY - JOUR

T1 - Combined hepatocellular-cholangiocarcinoma

T2 - A case report

AU - Toh, C. H.

AU - Cheung, Y. C.

AU - Ng, Shu Hang

AU - Lin, C. Y.

AU - Chan, S. C.

AU - Ng, K. K.

PY - 2004/12

Y1 - 2004/12

N2 - Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a rare primary liver tumour. We report a carrier of both HBV and HCV presenting with intermittent abdominal pain, fever, chillness and elevated á-fetoprotein (AFP) of 1197 ng/ml. Computed tomography showed an irregular hypodense mass in the left lateral segment of the liver with vague contrast enhancement and multiple regional lymphadenopathy. Hepatic angiogram showed that the mass was hypovascular and the left portal vein was occluded with a tapered end. Percutaneous ultrasound-guided core needle biopsy of the liver yielded HCC-CC. We suggest that HCC-CC should be considered in hypovascular liver tumours with striking elevation of serum AFP and multiple regional lymphadenopathy.

AB - Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a rare primary liver tumour. We report a carrier of both HBV and HCV presenting with intermittent abdominal pain, fever, chillness and elevated á-fetoprotein (AFP) of 1197 ng/ml. Computed tomography showed an irregular hypodense mass in the left lateral segment of the liver with vague contrast enhancement and multiple regional lymphadenopathy. Hepatic angiogram showed that the mass was hypovascular and the left portal vein was occluded with a tapered end. Percutaneous ultrasound-guided core needle biopsy of the liver yielded HCC-CC. We suggest that HCC-CC should be considered in hypovascular liver tumours with striking elevation of serum AFP and multiple regional lymphadenopathy.

KW - Combined hepatocellular-cholangiocarcinoma

KW - Liver neoplasm

UR - http://www.scopus.com/inward/record.url?scp=12344269675&partnerID=8YFLogxK

U2 - 10.1111/j.1742-1241.2004.00110.x

DO - 10.1111/j.1742-1241.2004.00110.x

M3 - 文章

C2 - 15646418

AN - SCOPUS:12344269675

SN - 1368-5031

VL - 58

SP - 1170

EP - 1173

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

IS - 12

ER -

Combined hepatocellular-cholangiocarcinoma: A case report

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this